Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Smith & Nephew PLC

SN-.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Medical Equipment, Supplies & Distribution ·

UK Large Cap Analyst: HOLD

Last Close

$14.58

▼ -1.29%

Market Cap $12.19B · Vol 2.14M

Key Metrics

P/E Ratio

19.80

FWD: 11.30

Market Cap

$12.19B

Large Cap

Div Yield

2.75%

Semi-annual dividend

EPS Growth

+18.02%

YoY

RSI (14)

38.72

Momentum

Beta

1.15

vs Market

52W High

$19.68

25.25% below

52W Low

$14.28

3.37% above

Volume

2.14M

Avg 2.91M

P/B

2.68

Price-to-book

ROE

16.75%

Return on equity

Free Float

99.76%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Smith & Nephew PLC (SN-.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SN-.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.83%

-6.32%

-6.15%

-20.65%

YTD

-13.77%

-22.78%

+9.45%

-24.44%

Financials & Valuation

TTM · Annual

Total Revenue	$6.16B
Net Income	$625.00M
Revenue Growth (YoY)	+4.59%
Gross Margin	68.25%
Operating Margin	17.49%
Net Profit Margin	10.14%
ROE	16.75%
ROA · ROIC	7.49% · 8.54%

P/E Ratio	19.80
Forward P/E (FY1)	11.30
PEG Ratio	0.45
P/S	2.36
P/B	2.68
P/FCF	17.10
EPS Growth	+18.02%
Outstanding Shares	837.42M

Technical Indicators

50-Day SMA	$15.37
200-Day SMA	$16.33
RSI (14)	38.72
Beta	1.15
52-Week High	$19.68
52-Week Low	$14.28

Volume Today	2.14M
Avg Daily Volume (30D)	2.91M
Relative Volume	0.74x
Volatility (10D)	25.16
Volatility (30D)	32.84
Free Float	99.76%

Analyst Consensus

HOLD

Current Price $14.58

Mean Target $17.38

52W Low$14.28 52W High$19.68

Current

Target

$14.28 $19.68

Current Analyst target

+19.24% upside potential · 20 analysts

Identifiers

ExchangeLSE

FIGIBBG001SDCF10

ISINGB0009223206

CountryUnited Kingdom

Sub-IndustryMedical Devices & Implants

Earnings DateNov 6, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SYK Stryker Corp +0.85% SNN Smith & Nephew PLC -1.35% GKOS Glaukos Corp -2.29% 300896.SZ Imeik Technology Development Co Ltd +2.13% 002901.SZ Double Medical Technology Inc +0.57%

Company Profile

Smith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The Company also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.